RxDoctor Payments Data

Eric Boyden, MD

Adult Reconstructive Orthopaedic Surgery · Reno, NVNPI 1518948512

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $5,666 of the $7,102 with a category attached, or 79.8%. Smith+Nephew accounts for 79.3% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $5,490 and has fallen 94.0% since, to $329 in 2025.

$7,102in general payments, 2019–2025

Across 27 payments — averaging $263.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$6K
  • Stryker$1K
  • Davol Inc.$27
  • Integra Lifesciences Corporation$16
  • Musculoskeletal Transplant Foundation Inc.$15
$60,130in research payments, 2019–2025

Across 22 payments — averaging $2733.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$60K

What the payments were for

  • Travel & lodging$5,66680%
  • Food & beverage$1,43620%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few adult reconstructive orthopaedic surgery providers in Nevadato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$322,664
Medicare patients
420
Services billed
1,771

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate18$901
Oxycodone Hcl88$481
Methylprednisolone46$269
Tramadol Hcl104$258
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen26$190
Amoxicillin43$43
Ondansetron Hcl16$38
Meloxicam22$36

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →